Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-13 5:25 pm Purchase |
2025-06-06 | 13G | Tango Therapeutics, Inc. TNGX |
Farallon Capital Partners, L.P. | 7,182,000 6.600% |
7,182,000 (New Position) |
Filing History |
| 2025-05-20 5:59 pm Sale |
2025-05-16 | 13D | Exelixis, Inc. EXEL |
Farallon Capital Partners, L.P. | 18,635,500 6.800% |
-4,804,000 (-20.50%) |
Filing History |
| 2025-05-15 09:24 am Purchase |
2024-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 13,262,045 7.900% |
1,931,000 (+17.04%) |
Filing History |
| 2025-05-15 09:23 am Purchase |
2024-09-30 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 11,331,045 6.900% |
2,954,820 (+35.28%) |
Filing History |
| 2025-05-15 09:22 am Purchase |
2024-04-12 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 8,376,225 5.100% |
1,626,021 (+24.09%) |
Filing History |
| 2025-05-13 3:45 pm Purchase |
2025-03-31 | 13G | Beam Therapeutics Inc. BEAM |
Farallon Capital Partners, L.P. | 9,972,980 9.990% |
1,733,857 (+21.04%) |
Filing History |
| 2025-05-08 4:09 pm Purchase |
2025-03-31 | 13G | Perspective Therapeutics, Inc. CATX |
Farallon Capital Partners, L.P. | 6,023,227 8.800% |
707,000 (+13.30%) |
Filing History |
| 2025-05-07 4:25 pm Purchase |
2025-03-31 | 13G | Aramark ARMK |
Farallon Capital Partners, L.P. | 16,241,996 6.100% |
2,603,656 (+19.09%) |
Filing History |
| 2025-05-07 4:21 pm Sale |
2025-03-31 | 13G | Elevation Oncology, Inc. ELEV |
Farallon Capital Partners, L.P. | 0 0.000% |
-3,527,482 (Position Closed) |
Filing History |
| 2025-03-05 5:01 pm Sale |
2025-03-05 | 13D | Exelixis, Inc. EXEL |
Farallon Capital Partners, L.P. | 23,439,500 8.400% |
-3,330,000 (-12.44%) |
Filing History |
| 2025-02-18 3:37 pm Purchase |
2025-02-11 | 13G | Aramark ARMK |
Farallon Capital Partners, L.P. | 13,638,340 5.100% |
2,001,403 (+17.20%) |
Filing History |
| 2025-02-18 3:36 pm Purchase |
2025-02-11 | 13G | The New York Times Company NYT |
Farallon Capital Partners, L.P. | 9,011,576 5.500% |
1,635,463 (+22.17%) |
Filing History |
| 2025-02-11 5:14 pm Purchase |
2024-12-31 | 13G | Savara Inc. SVRA |
Farallon Capital Partners, L.P. | 18,288,986 9.990% |
526,453 (+2.96%) |
Filing History |
| 2025-02-11 12:11 pm Purchase |
2024-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Farallon Capital Partners, L.P. | 2,108,262 9.900% |
83,262 (+4.11%) |
Filing History |
| 2025-02-10 2:33 pm Purchase |
2024-12-31 | 13G | AleAnna, Inc. ANNA |
Farallon Capital Partners, L.P. | 1,068,400 2.600% |
1,068,400 (New Position) |
Filing History |
| 2025-02-10 12:47 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Farallon Capital Partners, L.P. | 221,027 3.400% |
69,287 (+45.66%) |
Filing History |
| 2025-02-10 09:00 am Purchase |
2024-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Farallon Capital Partners, L.P. | 5,956,488 9.990% |
191,379 (+3.32%) |
Filing History |
| 2025-02-05 7:30 pm Purchase |
2024-12-31 | 13G | Beam Therapeutics Inc. BEAM |
Farallon Capital Partners, L.P. | 8,239,123 9.900% |
31,000 (+0.38%) |
Filing History |
| 2025-02-05 5:23 pm Sale |
2024-12-31 | 13G | The New York Times Company NYT |
Farallon Capital Partners, L.P. | 7,376,113 4.500% |
-2,100,678 (-22.17%) |
Filing History |
| 2025-02-05 4:28 pm Unchanged |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Farallon Capital Partners, L.P. | 3,527,482 6.000% |
0 (Unchanged) |
Filing History |